The weighted-average grant date fair value of stock options granted during 2017 was $2.00 per share. There were no stock options granted in 2019 or 2018. The total grant date fair value of stock options that vested during 2019, 2018, and 2017 was $2.8 million, $10.1 million and $20.2 million, respectively. As of December 31, 2019, the total unrecognized compensation expense related to unvested stock options was $0.3 million, which the Company expects to recognize over an estimated weighted average period of 0.2 years. As of December 31, 2019, the total unrecognized compensation expense related to unvested RSUs was $94.2 million, which the Company expects to recognize over an estimated weighted average period of 1.9 years. As of December 31, 2019, there was zero unrecognized compensation expense related to unvested warrants. [["", "", "Year Ended December 31,", ""], ["", "2019", "2018", "2017"], ["Cost of revenue", "$6,403", "$7,312", "$5,312"], ["Research and development", "44,855", "57,188", "54,123"], ["Sales and marketing", "11,585", "14,726", "14,959"], ["General and administrative", "14,896", "17,783", "17,187"], ["Total stock-based compensation expense", "$77,739", "$97,009", "$91,581"]]